1. Home
  2. ELUT

ELUT

Elutia Inc.

Logo Elutia Inc.

Health Care

Medical Specialities

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Founded: 2015 Country:
MD
Employees: N/A City: SILVER SPRING
Market Cap: 75.0M IPO Year: 2020
Target Price: $4.50 AVG Volume (30 days): 54.0
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.07 EPS Growth: N/A
52 Week Low/High: $1.10 - $4.19 Next Earning Date: 05-08-2024
Revenue: $24,745,000 Revenue Growth: 3.76%
Revenue Growth (this year): 21.19% Revenue Growth (next year): 73.81%

Share on Social Networks: